These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 29604591

  • 1. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X, Quan J, Li Z, Zhao L, Zhou L, Jinling X, Weijie X, Guan X, Li H, Yang S, Gui Y, Lai Y.
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [Abstract] [Full Text] [Related]

  • 2. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
    Liu S, Wang Y, Li W, Yu S, Wen Z, Chen Z, Lin F.
    Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
    [Abstract] [Full Text] [Related]

  • 3. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X, Li Z, Zhao L, Quan J, Zhou L, Xu J, Xu W, Guan X, Li H, Yang S, Gui Y, Lai Y.
    Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
    [Abstract] [Full Text] [Related]

  • 4. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C, Li Z, Chen P, Quan J, Pan X, Zhao L, Zhou L, Lai Y, He T, Xu W, Xu J, Guan X, Li H, Yang S, Hu Y, Lai Y.
    Life Sci; 2018 Sep 15; 209():481-489. PubMed ID: 30138594
    [Abstract] [Full Text] [Related]

  • 5. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Li Z, Lin C, Zhao L, Zhou L, Pan X, Quan J, Peng X, Li W, Li H, Xu J, Xu W, Guan X, Chen Y, Lai Y.
    Biomed Pharmacother; 2018 Sep 15; 105():461-469. PubMed ID: 29883941
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y, Chen D, Su Z, Li Y, Liu J, Jin L, Shi M, Jiang Z, Qi Z, Gui Y, Yang S, Mao X, Wu X, Lai Y.
    Mol Med Rep; 2016 Feb 15; 13(2):1420-6. PubMed ID: 26648244
    [Abstract] [Full Text] [Related]

  • 7. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
    Quan J, Pan X, Li Y, Hu Y, Tao L, Li Z, Zhao L, Wang J, Li H, Lai Y, Zhou L, Lin C, Gui Y, Ye J, Zhang F, Lai Y.
    Biomed Pharmacother; 2019 Feb 15; 110():656-666. PubMed ID: 30551118
    [Abstract] [Full Text] [Related]

  • 8. miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma.
    Sun C, Sun C, Zhou Y, Yang G, Li G, Xiang C, Ding X, Sun J.
    Mol Med Rep; 2019 Dec 15; 20(6):5208-5215. PubMed ID: 31661131
    [Abstract] [Full Text] [Related]

  • 9. Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.
    Zhou L, Pan X, Li Z, Chen P, Quan J, Lin C, Lai Y, Xu J, Xu W, Guan X, Li H, Gui Y, Lai Y.
    Biomed Pharmacother; 2018 Sep 15; 105():1155-1163. PubMed ID: 30021352
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma.
    Zhao L, Quan J, Li Z, Pan X, Wang J, Xu J, Xu W, Guan X, Li H, Yang S, Gui Y, Chen Y, Lai Y.
    Int J Mol Med; 2019 Jan 15; 43(1):525-534. PubMed ID: 30320376
    [Abstract] [Full Text] [Related]

  • 11. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M, Gu M, Zhang K, Zhou J, Wang Z, Da J.
    Diagn Pathol; 2015 Apr 09; 10():24. PubMed ID: 25890121
    [Abstract] [Full Text] [Related]

  • 12. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
    Peng H, Wang X, Zhang P, Sun T, Ren X, Xia Z.
    Int J Clin Exp Pathol; 2015 Apr 09; 8(2):2259-66. PubMed ID: 25973137
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y, Chen D, Jin L, Liu J, Su Z, Li Y, Gui Y, Lai Y.
    Mol Med Rep; 2016 Feb 09; 13(2):1895-901. PubMed ID: 26708577
    [Abstract] [Full Text] [Related]

  • 14. MiR-411 functions as a tumor suppressor in renal cell cancer.
    Zhang X, Zhang M, Cheng J, Lv Z, Wang F, Cai Z.
    Int J Biol Markers; 2017 Oct 31; 32(4):e454-e460. PubMed ID: 28708205
    [Abstract] [Full Text] [Related]

  • 15. Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.
    Zhu S, Huang Y, Su X.
    Med Sci Monit; 2016 Jan 18; 22():183-90. PubMed ID: 26779781
    [Abstract] [Full Text] [Related]

  • 16. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL, Pan WG, Li KL, Mao YJ, Liu SD, Zhang RM.
    Cancer Biother Radiopharm; 2020 Jun 18; 35(5):377-386. PubMed ID: 31971830
    [Abstract] [Full Text] [Related]

  • 17. Identification of miR‑130b as an oncogene in renal cell carcinoma.
    Li Y, Chen D, Li Y, Jin L, Liu J, Su Z, Qi Z, Shi M, Jiang Z, Gui Y, Yang S, Mao X, Lai Y.
    Mol Med Rep; 2016 Feb 18; 13(2):1902-8. PubMed ID: 26717956
    [Abstract] [Full Text] [Related]

  • 18. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R, Kim SS, Ding Q, Scorilas A, Lin S, Khella HW, Boulos C, Ibrahim G, Yousef GM.
    Urol Oncol; 2019 Dec 18; 37(12):955-963. PubMed ID: 31635993
    [Abstract] [Full Text] [Related]

  • 19. Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
    Li Y, Jin L, Chen D, Liu J, Su Z, Yang S, Gui Y, Mao X, Nie G, Lai Y.
    Mol Med Rep; 2016 Jul 18; 14(1):560-6. PubMed ID: 27175581
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.